NasdaqGS - Delayed Quote USD
Caribou Biosciences, Inc. (CRBU)
0.7743
-0.0157
(-1.99%)
At close: May 9 at 4:00:00 PM EDT
0.8129
+0.04
+(4.99%)
After hours: May 9 at 6:37:05 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 363,699 | 9 |
| Sales | 10,692 | 3 |
| Net Shares Purchased (Sold) | 353,007 | 12 |
| Total Insider Shares Held | 9.14M | -- |
| % Net Shares Purchased (Sold) | 4.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HAURWITZ RACHEL E. PH.D. Chief Executive Officer | Purchase at price 1.02 per share. | Indirect | 20,400 | Mar 14, 2025 |
| MCCLUNG BARBARA G Officer | Sale at price 1.35 per share. | Direct | 4,811 | Feb 21, 2025 |
| KANNER STEVEN B. Officer | Sale at price 1.35 per share. | Direct | 4,811 | Feb 21, 2025 |
| KHAN RUHI AHMAD Officer | Sale at price 1.35 per share. | Direct | 4,811 | Feb 21, 2025 |
| MCCLUNG BARBARA G Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| HAURWITZ RACHEL E. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| KELLY TIMOTHY P Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| KANNER STEVEN B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| KHAN RUHI AHMAD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| ALBERTSON TINA M. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| RYALI SRIRAM Chief Financial Officer | Purchase at price 1.42 per share. | Direct | 24,651 | Jan 29, 2025 |
| FISCHESSER RYAN M Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 20, 2024 |
| MCCLUNG BARBARA G Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| HAURWITZ RACHEL E. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| O'BYRNE JASON Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| KANNER STEVEN B. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| KHAN RUHI AHMAD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2024 |
| KANNER STEVEN B. Officer | Conversion of Exercise of derivative security at price 2.69 per share. | Direct | 82,252 | Feb 6, 2024 |
| HAURWITZ RACHEL E. PH.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.96 per share. | Direct | 29,600 | Jun 8, 2023 |
Related Tickers
VERV Verve Therapeutics, Inc.
4.2300
-5.58%
PRME Prime Medicine, Inc.
1.3000
-1.52%
NTLA Intellia Therapeutics, Inc.
8.12
-1.93%
BEAM Beam Therapeutics Inc.
17.41
+0.93%
ALLO Allogene Therapeutics, Inc.
1.1600
-1.69%
EDIT Editas Medicine, Inc.
1.4500
+4.32%
FATE Fate Therapeutics, Inc.
1.0400
+0.97%
VOR Vor Biopharma Inc.
0.1513
-5.44%
SANA Sana Biotechnology, Inc.
1.8200
+0.55%
BLUE bluebird bio, Inc.
3.5000
-5.66%